Tissue Factor signaling: A multi-faceted function in biological processes

Frontiers in Bioscience - Scholar

Volumn 3 S, Issue 4, 2011, Pages 1500-1510

  Van Den Hengel, Lisa G ^a   Versteeg, Henri H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Angiogenesis; Cancer; Cytoplasmic Domain; Factor VIIa; Integrin; PAR 2; Review; Sepsis; Signaling; Tissue factor

Indexed keywords

BLOOD CLOTTING FACTOR 7A; CALCIUM; PROTEINASE ACTIVATED RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 2; THROMBOPLASTIN; BETA1 INTEGRIN;

APOPTOSIS; ARTICLE; BIOLOGICAL FUNCTIONS; CALCIUM SIGNALING; CELL MIGRATION; GENE EXPRESSION REGULATION; INTRACELLULAR SIGNALING; PHYSIOLOGICAL PROCESS; PROTEIN SYNTHESIS; BIOLOGICAL MODEL; CELL MOTION; GENETICS; HUMAN; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGY; PROTEIN PROCESSING; SIGNAL TRANSDUCTION;

ANTIGENS, CD29; APOPTOSIS; CALCIUM; CELL MOVEMENT; FACTOR VIIA; HUMANS; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, PROTEINASE-ACTIVATED; SIGNAL TRANSDUCTION; THROMBOPLASTIN;

EID: 80053098063     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: None     Document Type: Article

References (97)

1. T.A. Drake, J.H. Morrissey, T.S. Edgington: Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol 134, 1087-1097 (1989)
2. R.A. Fleck, L.V. Rao, S.I. Rapaport, N. Varki: Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thromb Res 59, 421-437 (1990)
3. S.K. Mandal, U.R. Pendurthi, L.V. Rao: Cellular localization and trafficking of tissue factor. Blood 107, 4746-4753 (2006)
4. B. Osterud, S.I. Rapaport: Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathwayfor initiating blood coagulation. Proc Natl Acad Sci U S A 74, 5260-5264 (1977)
5. P. Carmeliet, N. Mackman, L. Moons, T. Luther, P. Gressens, I. van Vlaenderen, H. Demunck, M. Kasper , G. Breier, P. Evrard, M. Muller, W. Risau, T. Edgington, D. Collen: Role of tissue factor in embryonic blood vessel development. Nature 383, 73-75 (1996)
6. T.H. Bugge, Q. Xiao, K.W. Kombrinck, M.J. Flick, K. Holmback, M.J. Danton, M.C. Colbert, D.P. Witte, K. Fujikawa, E.W. Davie, J.L. Degen: Fatal embryonic bleeding events in mice lacking tissue factor, the cellassociated initiator of blood coagulation. Proc Natl Acad Sci U S A 93, 6258-6263 (1996)
7. J.R. Toomey, K.E. Kratzer, N.M. Lasky, J.J. Stanton, G.J. Jr. Broze: Targeted disruption of the murine tissue factor gene results in embryonic lethality. Blood 88, 1583-1587 (1996)
8. R.T. Poon, C.P. Lau, J.W. Ho, W.C. Yu, S.T. Fan, J. Wong: Tissue factor expression correlates with tumor angiogenesis and invasiveness in human hepatocellular carcinoma. Clin Cancer Res 9, 5339-5345 (2003)
9. M. Sawada, S. Miyake, S. Ohdama, O. Matsubara, S. Masuda, K. Yakumaru, Y. Yoshizawa: Expression of tissue factor in non-small-cell lung cancers and its relationship to metastasis. Br J Cancer 79, 472-477 (1999)
10. T.A. Drake, J. Cheng, A. Chang, F.B. Jr. Taylor: Expression of tissue factor, thrombomodulin, and Eselectin in baboons with lethal Escherichia coli sepsis. Am J Pathol 142, 1458-1470 (1993)
11. C. Lupu, A.D. Westmuckett, G. Peer, L. Ivanciu, H. Zhu, F.B. Jr. Taylor, F. Lupu: Tissue factor-dependent coagulation is preferentially up-regulated within arterial branching areas in a baboon model of Escherichia coli sepsis. Am J Pathol 167, 1161-1172 (2005)
12. J. Vickers, S. Russwurm, B. Dohrn, T. Portele, P. Spangenberg, K. Reinhart, W. Losche: Monocytetissue factor (CD142) and Mac-1 (CD11b) are increased in septic patients. Thromb Haemost 79, 1219-1220 (1998)
13. J. Erlich, C. Fearns, J. Mathison, R.J. Ulevitch, N. Mackman: Lipopolysaccharide induction of tissue factor expression in rabbits. Infect Immun 67, 2540-2546 (1999)
14. J.F. Bazan: Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci U S A 87, 6934-6938 (1990)
15. E. Camerer, W. Huang, S.R. Coughlin: Tissue factorand factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc Natl Acad Sci U S A 97, 5255-5260 (2000)
16. S.R. Coughlin: Protease-activated receptors in vascular biology. Thromb Haemost 86, 298-307 (2001)
17. M. Riewald, R.J. Petrovan, A. Donner, B.M. Mueller, W. Ruf: Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science 296, 1880-1882 (2002)
18. A. Kuliopulos, L. Covic, S.K. Seeley, P.J. Sheridan, J. Helin, C.E. Costello: Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy. Biochemistry 38, 4572-4585 (1999)
19. A. Boire, L. Covic, A. Agarwal, S. Jacques, S. Sherifi, A. Kuliopulos: PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell 120, 303-313 (2005)
20. M. Nakanishi-Matsui, Y.W. Zheng, D.J. Sulciner, E.J. Weiss, M.J. Ludeman, S.R. Coughlin: PAR3 is a cofactor for PAR4 activation by thrombin. Nature 404, 609-613 (2000)
21. P.J. O'Brien, N. Prevost, M. Molino, M.K. Hollinger, M.J. Woolkalis, D.S. Woulfe, L.F. Brass: Thrombin responses in human endothelial cells. Contributions from receptors other than PAR1 include the transactivation of PAR2 by thrombin-cleaved PAR1. J Biol Chem 275, 13502-13509 (2000)
22. M. Molino, E.S. Barnathan, R. Numerof, J. Clark, M. Dreyer, A. Cumashi, J.A. Hoxie, N. Schechter, M. Woolkalis, L.F. Brass: Interactions of mast cell tryptase with thrombin receptors and PAR-2. J Biol Chem 272, 4043-4049 (1997)
23. M. Riewald, V.V. Kravchenko, R.J. Petrovan, P.J. O'Brien, L.F. Brass, R.J. Ulevitch, W. Ruf: Gene induction by coagulation factor Xa is mediated by activation of protease-activated receptor 1. Blood 97, 3109-3116 (2001)
24. M.J. Berridge: Inositol trisphosphate and calcium signalling. Nature 361, 315-325 (1993)
25. J.A. Rottingen, T. Enden, E. Camerer, J.G . Iversen, H. Prydz: Binding of human factor VIIa to tissue factor induces cytosolic Ca2+ signals in J82 cells, transfected COS-1 cells, Madin-Darby canine kidney cells and in human endothelial cells induced to synthesize tissue factor. J Biol Chem 270, 4650-4660 (1995)
26. E. Camerer, J.A. Rottingen, J.G. Iversen, H. Prydz: Coagulation factors VII and X induce Ca2+ oscillations in Madin-Darby canine kidney cells only when proteolyticallyactive. J Biol Chem 271, 29034-29042 (1996)
27. H.H. Versteeg, H.L. Bresser, C.A. Spek, D.J. Richel, S.J. van Deventer, M.P. Peppelenbosch: Regulation of the p21Ras-MAP kinase pathway byfactor VIIa. J Thromb Haemost 1, 1012-1018 (2003)
28. L.C. Petersen, O. Thastrup, G. Hagel, B.B. Sorensen, P.O. Freskgard, L.V. Rao, M. Ezban: Exclusion of known protease-activated receptors in factor VIIa-induced signal transduction. Thromb Haemost 83, 571-576 (2000)
29. U.R. Pendurthi, D. Alok, L.V. Rao: Binding of factor VIIa to tissue factor induces alterations in gene expression in human fibroblast cells: up-regulation of poly(A) polymerase. Proc Natl Acad Sci U S A 94, 12598-12603 (1997)
30. E. Camerer, E. Gjernes, M. Wiiger, S. Pringle, H. Prydz: Binding of factor VIIa to tissue factor on keratinocytes induces gene expression. J Biol Chem 275, 6580-6585 (2000)
31. U.R. Pendurthi, K.E. Allen, M. Ezban, L.V. Rao: Factor VIIa and thrombin induce the expression of Cyr61 and connective tissue growth factor, extracellular matrix signaling proteins that could act as possible downstream mediators in factor VIIa x tissue factor-induced signal transduction. J Biol Chem 275, 14632-14641 (2000)
32. H.H. Versteeg, F. Schaffner, M. Kerver, H.H. Petersen, J. Ahamed, B. Felding-Habermann, Y. Takada, B.M. Mueller, W. Ruf: Inhibition of tissue factor signaling suppresses tumor growth. Blood 111, 190-199 (2008)
33. T. Albrektsen, B.B. Sorensen, G.M. Hjorto, J. Fleckner, L.V. Rao, L.C. Petersen: Transcriptional program induced by factor VIIa-tissue factor, PAR1 and PAR2 in MD AMB- 231 cells. J Thromb Haemost 5, 1588-1597 (2007)
34. L.K. Poulsen, N. Jacobsen, B.B. Sorensen, N.C. Bergenhem, J.D. Kelly, D.C. Foster, O. Thastrup, M. Ezban, L.C. Petersen: Signal transduction via the mitogenactivated protein kinase pathway induced by binding of coagulation factor VIIa to tissue factor. J Biol Chem 273, 6228-6232 (1998)
35. B.B. Sorensen, P.O. Freskgard, L.S. Nielsen, L.V. Rao, M. Ezban, L.C. Petersen: Factor VIIa-induced p44/42 mitogen-activated protein kinase activation requires the proteolytic activity of factor VIIa and is independent of the tissue factor cytoplasmic domain. J Biol Chem 274, 21349-21354 (1999)
36. E. Camerer, J.A. Rottingen, E. Gjernes, K. Larsen, A.H. Skartlien, J.G. Iversen, H. Prydz: Coagulation factors VIIa and Xa induce cell signaling leading to up-regulation of the egr-1 gene. J Biol Chem 274, 32225-32233 (1999)
37. X. Wang, E. Gjernes, H. Prydz: Factor VIIa induces tissue factor-dependent up-regulation of interleukin-8 in a human keratinocyte line. J Biol Chem 277, 23620-23626 (2002)
38. H.H. Versteeg, C.A. Spek, S.H. Slofstra, S.H. Diks, D.J. Richel, M.P. Peppelenbosch: FVIIa:TF induces cell survival via G12/G13-dependent Jak/STAT activation and BclXL production. Circ Res 94, 1032-1040 (2004)
39. J. Fang, L. Gu, N. Zhu, H. Tang, C.S. Alvarado, M. Zhou: Tissue factor/FVIIa activates Bcl-2 and prevents doxorubicin-induced apoptosis in neuroblastoma cells. BMC Cancer 8, 69 (2008)
40. B.B. Sorensen, L.V. Rao, D. Tornehave, S. Gammeltoft, L.C. Petersen: Antiapoptotic effect of coagulation factor VIIa. Blood 102, 1708-1715 (2003)
41. H.H. Versteeg, C.A. Spek, D.J. Richel, M.P. Peppelenbosch: Coagulation factors VIIa and Xa inhibit apoptosis and anoikis. Oncogene 23, 410-417 (2004)
42. H.H. Versteeg, D.J. Richel, M.P. Peppelenbosch, C.A. Spek: Concerted action of coagulation factors on cell survival. J Thromb Haemost 2, 673-674 (2004)
43. H.H. Versteeg, K.S. Borensztajn, M.E. Kerver, W. Ruf, P.H. Reitsma, C.A. Spek, M.P. Peppelenbosch: TF:FVIIaspecific activation of CREB upregulates proapoptotic proteins via protease-activated receptor-2. J Thromb Haemost 6, 1550-1557 (2008)
44. A. Siegbahn, M. Johnell, A . Nordin, M. Aberg, T. Velling: TF/FVIIa transactivate PDGFRbeta to regulate PDGF-BB-induced chemotaxis in different cell types: involvement of Src and PLC. Arterioscler Thromb Vasc Biol 28, 135-141 (2008)
45. G.M. Hjortoe, L.C. Petersen, T. Albrektsen, B.B. Sorensen, P.L. Norby, S.K. Mandal, U.R. Pendurthi, L.V. Rao: Tissue factor-factor VIIa-specific up-regulation of IL- 8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration. Blood 103, 3029-3037 (2004)
46. X. Jiang, S. Zhu, T.S. Panetti, M.E. Bromberg: Formation of tissue factor-factor VIIa-factor Xa complex induces activation of the mTOR pathway which regulates migration of human breast cancer cells. Thromb Haemost 100, 127-133 (2008)
47. H.H. Versteeg, I. Hoedemaeker, S.H. Diks, J.C. Stam, M. Spaargaren, P.M. van Bergenen Henegouwen, S.J. van Deventer, M.P. Peppelenbosch: Factor VIIa/tissue factor-induced signaling via activation of Src-like kinases, phosphatidylinositol 3-kinase, and Rac. J Biol Chem 275, 28750-28756 (2000)
48. A. Dorfleutner, E. Hintermann, T. Tarui, Y. Takada, W. Ruf: Cross-talk of integrin alpha3beta1 and tissue factor in cell migration. Mol Biol Cell 15, 4416-4425 (2004)
49. D .R. Morris, Y. Ding, T.K. Ricks, A. Gullapalli, B.L. Wolfe, J. Trejo: Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells. Cancer Res 66, 307-314 (2006)
50. M. Grosser, V. Magdolen, G. Baretton, T. Luther, S. Albrecht: Gene expression analysis of HUVEC in response to TF-binding. Thromb Res (2010) doi:10.1016/j.thromres.2010.11.024
51. M.E. Collier, C. Ettelaie: Induction of endothelial cell proliferation by recombinant and microparticletissue factor involves beta1-integrin and extracellular signal regulated kinase activation. Arterioscler Thromb Vasc Biol 30, 1810-1817 (2010)
52. I. Ott, B. Weigand, R. Michl, I. Seitz, N. Sabbari- Erfani, F.J. Neumann, A. Schomig: Tissue factor cytoplasmic domain stimulates migration by activation of the GTPase Rac1 and the mitogen-activated protein kinase p38. Circulation 111, 349-355 (2005)
53. I. Ott, E.G. Fischer, Y. Miyagi, B.M. Mueller, W. Ruf: A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280. J Cell Biol 140, 1241-1253 (1998)
54. Y.W. van den Berg, L.G. van den Hengel, H.R. Myers, O. Ayachi, E. Jordanova, W. Ruf, C.A. Spek, P.H. Reitsma, V.Y. Bogdanov, H.H. Versteeg: Alternatively spliced tissue factor induces angiogenesis through integrin ligation. Proc Natl Acad Sci U S A 106, 19497-19502 (2009)
55. J. Ahamed, H.H. Versteeg, M. Kerver, V.M. Chen, B.M. Mueller, P.J. Hogg, W. Ruf: Disulfide isomerization switches tissue factor from coagulation to cell signaling. Proc Natl Acad Sci U S A 103, 13932-13937 (2006)
56. U.R. Pendurthi, S. Ghosh, S.K. Mandal, L.V. Rao: Tissue factor activation: is disulfide bond switching a regulatory mechanism? Blood 110, 3900-3908 (2007)
57. L.C. Petersen, T. Albrektsen, G.M. Hjorto, M. Kjalke, S.E. Bjorn, B.B. Sorensen: Factor VIIa/tissue factor-dependent gene regulation and pro-coagulant activity: effect of factor VIIa concentration. Thromb Haemost 98, 909-911 (2007)
58. J. Disse, H.H. Petersen, K.S. Larsen, E. Persson, N. Esmon, C.T. Esmon, L. Teyton, L.C. Petersen, W. Ruf: The endothelial protein c receptor supports tissue factor ternary coagulation initiation complex signaling through proteaseactivated receptors. J Biol Chem (2010) doi: 10.1074/jbc.M110.201228
59. V. Awasthi, S.K. Mandal, V. Papanna, L.V. Rao, U.R. Pendurthi: Modulation of tissue factor-factor VIIa signaling by lipid rafts and caveolae. Arterioscler Thromb Vasc Biol 27, 1447-1455 (2007)
60. M.D. Resh: Palmitoylation of ligands, receptors, and intracellular signaling molecules. Sci STKE 359, re14 (2006)
61. J. Ahamed, W. Ruf: Protease-activated receptor 2- dependent phosphorylation of the tissue factor cytoplasmic domain. J Biol Chem 279, 23038-23044 (2004)
62. A. Dorfleutner, W. Ruf: Regulation of tissue factor cytoplasmic domain phosphorylation by palmitoylation. Blood 102, 3998-4005 (2003)
63. M. Belting, M.I. Dorrell, S. Sandgren, E. Aguilar, J. Ahamed, A. Dorfleutner, P. Carmeliet, B.M. Mueller, M. Friedlander, W. Ruf: Regulation of angiogenesis by tissue factor cytoplasmic domain signaling. Nat Med 10, 502-509 (2004)
64. E . Melis, L. Moons, M. de Mol, J.M. Herbert, N. Mackman, D. Collen, P. Carmeliet, M. Dewerchin: Targeted deletion of the cytosolic domain of tissue factor in mice does not affect development. Biochem Biophys Res Commun 286, 580-586 (2001)
65. G.C. Parry, N. Mackman: Mouse embryogenesis requires the tissue factor extracellular domain but not the cytoplasmic domain. J Clin Invest 105, 1547-1554 (2000)
66. P. Cirillo, G. Cali, P. Golino, P. Calabro, L. Forte, S. de Rosa, M. Pacileo, M. Ragni, F. Scopacasa, L. Nitsch, M. Chiariello: Tissue factor binding of activated factor VII triggers smooth muscle cell proliferation via extracellular signal-regulated kinase activation. Circulation 109, 2911-2916 (2004)
67. I. Ott, C. Michaelis, M. Schuermann, B. Steppich, I. Seitz, M. Dewerchin, D. Zohlnhofer, R. Wessely, M. Rudelius, A. S chomig, P. Carmeliet: Vascular remodeling in mice lacking the cytoplasmic domain of tissue factor. Circ Res 97, 293-298 (2005)
68. K. Marutsuka, K. Hatakeyama, Y. Sato, A. Yamashita, A. S umiyoshi, Y. Asada: Protease-activated receptor 2 (PAR2) mediates vascular smooth muscle cell migration induced by tissue factor/factor VIIa complex. Thromb Res 107, 271-276 (2002)
69. Z. Xu, H. Xu, V.A. Ploplis, F.J. Castellino: Factor VII deficiency impairs cutaneous wound healing in mice. Mol Med 16, 167-176 (2010)
70. T.A. Martin, K.G. Harding, W.G. Jiang: Regulation of angiogenesis and endothelial cell motility by matrix-bound fibroblasts. Angiogenesis 3, 69-76 (1999)
71. V. Ollivier, J. Chabbat, J.M. Herbert, J. Hakim, D. de Prost: Vascular endothelial growth factor production by fibroblasts in response to factor VIIa binding to tissue factor involves thrombin and factor Xa. Arterioscler Thromb Vasc Biol 20, 1374-1381 (2000)
72. N.S. Callander, N. Varki, L.V. Rao: Immunohistochemical identification of tissue factor in solid tumors. Cancer 70, 1194-1201 (1992)
73. J.L. Yu, L. May, V. Lhotak, S. Shahrzad, S. Shirasawa, J.I. Weitz, B.L. Coomber, N. Mackman, J.W. Rak: Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. Blood 105, 1734-1741 (2005)
74. C.C. M ilsom, J.L. Yu, N. Mackman, J. Micallef, G.M. Anderson, A. Guha, J.W. Rak: Tissue factor regulation by epidermal growth factor receptor and epithelial-tomesenchymal transitions: effect on tumor initiation and angiogenesis. Cancer Res 68, 10068-10076 (2008)
75. N. Magnus, D. Garnier, J. Rak: Oncogenic epidermal growth factor receptor up-regulates multiple elements of the tissue factor signaling pathway in human glioma cells . Blood 116, 815-818 (2010)
76. Y. Zhang, Y. Deng, T. Luther, M. Muller, R. Ziegler, R. Waldherr, D.M. Stern, P.P. Nawroth: Tissue factor controls the balance of angiogenicand antiangiogenic properties of tumor cells in mice. J Clin Invest 94, 1320-1327 (1994)
77. C.V. Ngo, K. Picha, F. McCabe, H. Millar, R. Tawadros, S.H. Tam, M.T. Nakada, G.M. Anderson: CNTO 859, a humanized anti-tissue factor monoclonal antibody, is a potent inhibitor of breast cancer metastasis and tumor growth in xenograft models. Int J Cancer 120, 1261-1267 (2007)
78. T.A. Hembrough, G.M. Swartz, A. Papathanassiu, G.P. Vlasuk, W.E. Rote, S.J. Green, V.S. Pribluda: Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism. Cancer Res 63, 299 7-3000 (2003)
79. J. Zhao, G. Aguilar, S. Palencia, E. Newton, A. Abo: rNAPc2 inhibits colorectal cancer in mice through tissue factor. Clin Cancer Res 15, 208-216 (2009)
80. H.H. Versteeg, F. Schaffner, M. Kerver, L.G. Ellies, P. Andrade-Gordon, B.M. Mueller, W. Ruf: Proteaseactivated receptor (PAR) 2, but not PAR1, signaling promotes the development of mammary adenocarcinoma in polyoma middle T mice. Cancer Res 68, 7219-7227 (2008)
81. F. Schaffner, H.H. Versteeg, A. Schillert, N. Yokota, L.C. Petersen, B.M. Mueller, W. Ruf: Cooperation of tissue factor cytoplasmic domain and PAR2 signaling in breast cancer development. Blood 116, 6106-13 (2010)
82. L. Ryden, D. Grabau, F. Schaffner, P.E. Jonsson, W. Ruf, M. Belting: Evidence for tissue factor phosphorylation and its correlation with protease-activated receptor expression and the prognosis of primary breast cancer. Int J Cancer 126, 2330-2340 (2010)
83. H. Muth, I. Kreis, R. Zimmermann, H. Tillmanns, H. Holschermann: Differential gene expression in activated monocyte-derived macrophages following binding of factor VIIa to tissue factor. Thromb Haemost 94, 1028-1034 (2005)
84. M.A. Cunningham, P. Romas, P. Hutchinson, S.R. Holdsworth, P.G. Tipping: Tissue factor and factor VIIa receptor/ligand interactions induce proinflammatory effects in macrophages. Blood 94, 3413-3420 (1999)
85. E. de Jonge, P.W. Friederich, G.P. Vlasuk, W.E. Rote, M.B. Vroom, M. Levi, T. van der Poll: Activation of coagulation by administration of recombinant factor VIIa elicits interleukin 6 (IL-6) and IL-8 release in healthy human subjects. Clin Diagn Lab Immunol 10, 495-497 (2003)
86. S. Weijer, S.H. Schoenmakers, S. Florquin, M. Levi, G.P. Vlasuk, W.E. Rote, P.H. Reitsma, C.A. Spek, T . van der Poll: Inhibition of the tissue factor/factor VIIa pathway does not influence the inflammatory or antibacterial response to abdominal sepsis induced by Escherichia coli in mice. J Infect Dis 189, 2308-2317 (2004)
87. A.P. Dackiw, I.D. McGilvray, M. Woodside, A.B. Nathens, J.C. Marshall, O.D. Rotstein: Prevention of endotoxin-induced mortality by antitissue factor immunization. Arch Surg 131, 1273-1278 (1996)
88. R. Pawlinski, B. Pedersen, G. Schabbauer, M. Tencati, T. Holscher, W. Boisvert, P. Andrade-Gordon, R.D. Frank, N. Mackman: Role of tissue factor and protease-activated receptors in a mousemodel of endotoxemia. Blood 103, 1342-1347 (2004)
89. F.B. Taylor, A.C. Chang, G. Peer, A. Li, M. Ezban, U. Hedner: Active site inhibited factor VIIa (DEGR VIIa) attenuates the coagulantand interleukin-6 and -8, but not tumor necrosis factor, responses of the baboon to LD100 Escherichia coli. Blood 91, 1609-1615 (1998)
90. F.B. Jr. Taylor: Role of tissue factor and factor VIIa in the coagulant and inflammatory response to LD100 Escherichia coli in the baboon. Haemostasis 26 Suppl 1, 83-91 (1996)
91. L. Sharma, E. Melis, M.J. Hickey, C.D. Clyne, J. Erlich, L.M. Khachigian, P . Davenport, E. Morand, P. Carmeliet, P.G. Tipping: The cytoplasmic domain of tissue factor contributes to leukocyte recruitment and death in endotoxemia. Am J Pathol 165, 331-340 (2004)
92. U. J ohansson, C. Lawson, M. Dabare, D. Syndercombe- Court, A.C. Newland, G.L. Howells, M.G. Macey: Human peripheral blood monocytes express protease receptor-2 and respond to receptor activation by production of IL-6, IL-8, and IL -1{beta}. J Leukoc Biol 78, 967-975 (2005)
93. S. Nystedt, V. Ramakrishnan, J. Sundelin: The proteinase-activated receptor 2 is induced by inflammatory mediators in human endothelial cells. Comparison with the thrombin receptor. J Biol Chem 271, 14910-14915 (1996)
94. J.R. Hamilton, A.G. Frauman, T.M. Cocks: Increased expression of protease-activated receptor-2 (PAR2) and PAR4 in human coronary artery by inflammatory stimuli unveils endothelium-dependent relaxations to PAR2 and PAR4 agonists. Circ Res 89, 92-98 (2001)
95. N. Vergnolle: Proteinase-activated receptor-2-activating peptides induce leukocyte rolling, adhesion, and extravasation in vivo. J Immunol 163, 5064-5069 (1999)
96. J.R. Lindner, M.L. Kahn, S.R. Coughlin, G.R. S ambrano, E. Schauble, D. Bernstein, D. Foy, A. Hafezi- Moghadam, K. Ley: Delayed onset of inflammation in protease-activated receptor-2-deficient mice. J Immunol 165, 6504-6510 (2000)
97. E. Camerer, I. Cornelissen, H. Kataoka, D.N. Duong, Y.W. Zheng, S.R. Coughlin: Roles of protease-activated receptors in a mouse model of endotoxemia. Blood 107, 3912-3921 (2006)